[go: up one dir, main page]

UA93017U - "nanovulin-bpx" medication - Google Patents

"nanovulin-bpx" medication

Info

Publication number
UA93017U
UA93017U UAU201404615U UAU201404615U UA93017U UA 93017 U UA93017 U UA 93017U UA U201404615 U UAU201404615 U UA U201404615U UA U201404615 U UAU201404615 U UA U201404615U UA 93017 U UA93017 U UA 93017U
Authority
UA
Ukraine
Prior art keywords
nanovulin
bpx
medication
aquakhelate
observed
Prior art date
Application number
UAU201404615U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Виктор Иванович Шеремета
Original Assignee
Национальный Университет Биоресурсов И Природопользования Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Университет Биоресурсов И Природопользования Украины filed Critical Национальный Университет Биоресурсов И Природопользования Украины
Priority to UAU201404615U priority Critical patent/UA93017U/en
Publication of UA93017U publication Critical patent/UA93017U/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"Nanovulin-BPX" medication contains sodium succinate and sodium glutamate. In addition, it contains copper aquakhelate and can be used provided the following proportions of its components are observed: %:
UAU201404615U 2014-04-29 2014-04-29 "nanovulin-bpx" medication UA93017U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201404615U UA93017U (en) 2014-04-29 2014-04-29 "nanovulin-bpx" medication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201404615U UA93017U (en) 2014-04-29 2014-04-29 "nanovulin-bpx" medication

Publications (1)

Publication Number Publication Date
UA93017U true UA93017U (en) 2014-09-10

Family

ID=56281705

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201404615U UA93017U (en) 2014-04-29 2014-04-29 "nanovulin-bpx" medication

Country Status (1)

Country Link
UA (1) UA93017U (en)

Similar Documents

Publication Publication Date Title
MX393936B (en) Combination of elafibranor or derivatives thereof with an anti-nash, anti-fibrotic or anti-cholestatic agent
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
SG10201803042PA (en) Anti-tim-3 antibodies
AU366476S (en) Bottle
MX2017004838A (en) Interleukin-15 compositions and uses thereof.
MY187540A (en) Compounds active towards bromodomains
MY191581A (en) Anti-pd-1 antibodies
SG10201808151RA (en) Cortistatin analogues and syntheses and uses thereof
JO3343B1 (en) Novel5-aminotetrahydroquinoline-2-carboxylic acids and their use
HK1220980A1 (en) Methods and compositions for treatment of pompe disease
MX2015015518A (en) Methods and compositions for the treatment of cancer.
MX2021010886A (en) Medicaments for slowing parkinson's disease.
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
AU365587S (en) Kettle
MY193650A (en) Extracellular matrix compositions
TWD165710S (en) Electrical connector
MX2016004802A (en) Anti-rsp02 and/or anti-rsp03 antibodies and their uses.
MX2020006596A (en) Hydroxyisoxazolines and derivatives thereof.
ZA201803476B (en) Anti-cd22 antibody-maytansine conjugates and methods of use thereof
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2017007577A (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof.
MX2020002585A (en) Hdac inhibitor in combination with immune checkpoint modulator for cancer therapy.
MY178960A (en) Hiv treatment formulation of atazanavir and cobicistat
PH12016501838A1 (en) Compounds and their methods of use
MX2015016603A (en) Corticosteroid compositions.